MedTrace Logo

CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma

NCT03611530 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2024-03-13

No results posted yet for this study

Summary

This is a randomized, parallel arm, multicenter, double-blind trial.

Patients with POAG will be randomized 1:1 ratio to receive:

* Prostaglandin analogue (PGA) monotherapy + CoQun® (Arm A)
* Prostaglandin analogue (PGA) monotherapy + Vehicle (Arm B)

Conditions

Interventions

DEVICE

Coqun® ophthalmic solution

Prostaglandin analogue (PGA) monotherapy + Coqun® ophthalmic solution

OTHER

Placebo ophthalmic solution

Prostaglandin analogue (PGA) monotherapy + Placebo ophthalmic solution

Sponsors & Collaborators

  • Mario Negri Institute for Pharmacological Research

    lead OTHER

Principal Investigators

  • Luciano Quaranta, MD PhD · Università degli Studi di Brescia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-04
Primary Completion
2022-04-29
Completion
2022-04-29

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03611530 on ClinicalTrials.gov